Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Wenstrup

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
The Journal of Biological Chemistry|April 26, 1996
Discordant expression of osteoblast markers in MC3T3-E1 cells that synthesize a high turnover matrixR J Wenstrup, J L Fowlkes, D P Witte, et al.
Genomics|August 1, 1992
Sequence analysis of a full-length cDNA for the murine pro alpha 2(I) collagen chain: comparison of the derived primary structure with human pro alpha 2(I) collagenC L Phillips, A L Morgan, L W Lever, et al.
American Journal of Medical Genetics|January 15, 1993
Mutations in the COL1A2 gene of type I collagen that result in nonlethal forms of osteogenesis imperfectaR J Wenstrup, L W Lever, C L Phillips, et al.
American Journal of Human Genetics|May 1, 1990
Distinct biochemical phenotypes predict clinical severity in nonlethal variants of osteogenesis imperfectaR J Wenstrup, M C Willing, B J Starman, et al.
American Journal of Medical Genetics|April 29, 1998
Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK)P Beighton, A De Paepe, B Steinmann, et al.
Human Mutation|January 1, 1992
Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a mutation in the COL1A2 gene of type I collagen. The mosaic parent exhibits phenotypic features of a mild form of the diseaseM J Edwards, R J Wenstrup, P H Byers, et al.
Endocrinology|June 1, 1991
Aluminum-induced mitogenesis in MC3T3-E1 osteoblasts: potential mechanism underlying neoosteogenesisL D Quarles, R J Wenstrup, S A Castillo, et al.
The Journal of Clinical Investigation|November 1, 1990
A substitution at a non-glycine position in the triple-helical domain of pro alpha 2(I) collagen chains present in an individual with a variant of the Marfan syndromeC L Phillips, A W Shrago-Howe, S R Pinnell, et al.
Human Molecular Genetics|March 21, 1998
Mutations of the alpha2(V) chain of type V collagen impair matrix assembly and produce ehlers-danlos syndrome type IK Michalickova, M Susic, M C Willing, et al.
The Journal of Investigative Dermatology|June 26, 1999
The Nf1 tumor suppressor regulates mouse skin wound healing, fibroblast proliferation, and collagen deposited by fibroblastsR P Atit, M J Crowe, D G Greenhalgh, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
The Journal of Biological Chemistry|April 26, 1996
Discordant expression of osteoblast markers in MC3T3-E1 cells that synthesize a high turnover matrixR J Wenstrup, J L Fowlkes, D P Witte, et al.
Genomics|August 1, 1992
Sequence analysis of a full-length cDNA for the murine pro alpha 2(I) collagen chain: comparison of the derived primary structure with human pro alpha 2(I) collagenC L Phillips, A L Morgan, L W Lever, et al.
American Journal of Medical Genetics|January 15, 1993
Mutations in the COL1A2 gene of type I collagen that result in nonlethal forms of osteogenesis imperfectaR J Wenstrup, L W Lever, C L Phillips, et al.
American Journal of Human Genetics|May 1, 1990
Distinct biochemical phenotypes predict clinical severity in nonlethal variants of osteogenesis imperfectaR J Wenstrup, M C Willing, B J Starman, et al.
American Journal of Medical Genetics|April 29, 1998
Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK)P Beighton, A De Paepe, B Steinmann, et al.
Human Mutation|January 1, 1992
Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a mutation in the COL1A2 gene of type I collagen. The mosaic parent exhibits phenotypic features of a mild form of the diseaseM J Edwards, R J Wenstrup, P H Byers, et al.
Endocrinology|June 1, 1991
Aluminum-induced mitogenesis in MC3T3-E1 osteoblasts: potential mechanism underlying neoosteogenesisL D Quarles, R J Wenstrup, S A Castillo, et al.
The Journal of Clinical Investigation|November 1, 1990
A substitution at a non-glycine position in the triple-helical domain of pro alpha 2(I) collagen chains present in an individual with a variant of the Marfan syndromeC L Phillips, A W Shrago-Howe, S R Pinnell, et al.
Human Molecular Genetics|March 21, 1998
Mutations of the alpha2(V) chain of type V collagen impair matrix assembly and produce ehlers-danlos syndrome type IK Michalickova, M Susic, M C Willing, et al.
The Journal of Investigative Dermatology|June 26, 1999
The Nf1 tumor suppressor regulates mouse skin wound healing, fibroblast proliferation, and collagen deposited by fibroblastsR P Atit, M J Crowe, D G Greenhalgh, et al.
Pageof 4